Loading organizations...
§ Venture Capital · Portola Valley, CA, USA
Longwood Fund is a venture capital firm creating and investing in science-based companies developing novel solutions for important medical problems. The firm acts as a value-add investor, actively supporting its portfolio from discovery to patient application. Longwood collaborates with world-class scientific co-founders, often taking active leadership roles to build ventures.
Longwood Fund was established in February 2010 by co-founders Christoph Westphal, Michelle Aldrich, and Richard Dipp. Their core insight focused on translating pioneering science into impactful medical products. Dr. Westphal, an experienced biotech CEO and investor, brought significant pedigree in founding and developing successful biotechnology companies.
The firm primarily serves academic institutions and scientific co-founders, ultimately benefiting patients needing advanced medical treatments. Longwood Fund's vision is to identify, cultivate, and accelerate groundbreaking scientific innovations into meaningful applications that improve human health, driving therapies from research to access.
Longwood Capital Partners has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series D in AnaptysBio in July 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2015 | AnaptysBio | $40.0M Series D | — | Frazier Healthcare Partners, Versant Ventures, Biomed Ventures, BVF Partners, Cormorant Asset Management, HBM Healthcare Investments, Novo Holdings |